Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Biocartis

Request full access

Develops diagnostic systems to reduce the cost and improve the efficacy of personalised medical treatments

Mechelen, BelgiumFounded 2007Biotech & Life Sciences

About Biocartis

Biocartis is a pioneering molecular diagnostics company dedicated to transforming molecular testing through its unique IdyllaTM platform. The company provides advanced diagnostic solutions designed to improve clinical practice for patients, clinicians, payers, and the broader healthcare industry. Biocartis operates in the molecular diagnostics market, focusing on oncology and infectious diseases. Its primary clients include hospitals, laboratories, and healthcare providers who require rapid and accurate diagnostic results. The business model revolves around the sale of diagnostic instruments and consumables, generating revenue through the continuous use of its proprietary platform and assays. Biocartis makes money by selling its IdyllaTM platform and associated diagnostic tests, which offer quick and reliable results, thereby enhancing patient care and operational efficiency in clinical settings.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2015

Biocartis in the Mechelen ecosystem

Live from Dealroom

The Biocartis office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • VLAIO- Team Bedrijfstrajecten Crossroads France-Wallonie-Vlaanderen

Series A5 investors entered at this stage

  • Aescap
  • Advent Venture Partners
  • Johnson & Johnson Development Corporation
  • KBC
  • Debiopharm Group

Series B and later6 investors entered at this stage

  • Wellcome Trust
  • PMV
  • Korys
  • RMM
  • Philips
  • Hitachi Chemical Diagnostics
Employees mapped 311 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Biocartis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.